Bradley Alford Buys Shares of PRGO $PRGO

Key Points

Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.

Bradley Alford, insider at Perrigo Company plc ($PRGO), bought 976 shares at an average price of $10.99, for a total transaction of $10,726.24. The trade was disclosed in a Form 4 filing with the Securities and Exchange Commission.

Perrigo Company plc Stock Down 26.1%

Shares of Perrigo Company plc ($PRGO) traded around $10.70 on Tuesday, down 26.1% for the day.

Last price$10.70
Market cap$2.03B
Forward P/E6.10
PEG ratio1.14
Beta0.54
52-week low$9.23
52-week high$23.95
50-day MA$11.55
200-day MA$12.18
Current ratio2.32
Quick ratio1.09
Debt-to-equity1.38

Perrigo Company plc Earnings

EPS (ttm)-$12.43
Revenue (ttm)$4.14B
Revenue growth-3.20%
Net margin-41.85%
Return on equity-48.75%
Next earningsNov 4, 2026

Perrigo Company plc Dividend

Annual dividend$1.16
Dividend yield801%
Payout ratio10950%
Ex-dividend dateAug 28, 2026

Analysts Set New Price Targets

Average target$16.50
High target$20
Low target$14
Analysts covering4

About Perrigo Company plc

Perrigo Company plc provides over-the-counter health and wellness solutions in the United States, Europe, and internationally. The company operates through Consumer Self-Care Americas and Consumer Self-Care International segments. It offers upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and oral electrolyte beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers. The company also offers healthy lifestyle products, such as smoking cessation and well-being products; skin care products consisting of dermatological care, scar management, lice treatment, and other products for various skin conditions; women's health products comprising feminine hygiene and contraceptives; vitamins, minerals, and supplements; and other miscellaneous self-care products. It sells its products under the Compeed, Dr. Fresh, Firefly, Good Sense, Good Start, Mederma, Nasonex, Plackers, Prevacid24HR, REACH, Rembrandt, Steripod, Opill, Solpadeine, Coldrex, Physiomer, NiQuitin, ACO, ellaOne, and Compeed brands. The company also offers contract manufacturing services. It sells its products through retail drug, supermarket, and mass merchandise chains; e-commerce stores; wholesalers; pharmacies; drug and grocery retailers; and para-pharmacies. The company was formerly known as Perrigo Company and changed its name to Perrigo Company plc in December 2013. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.

ExchangeNYSE
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
HeadquartersDublin, Ireland
CEOMr. Albert Ange Manzone
Employees8,100

Get Perrigo Company plc alerts

New 13F filings, insider trades, and analyst moves on $PRGO, sent to your inbox. Free, and you can unsubscribe anytime.

This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.